Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Group 1 - Pulse Biosciences, Inc. is set to present at the 44th Annual J.P. Morgan 2026 Healthcare Conference in San Francisco on January 14, 2026, at 3:45 PM PT [1][2] - The company utilizes its proprietary nPulse™ technology, which employs Nanosecond Pulsed Field Ablation (nsPFA) to deliver nanosecond pulses of electrical energy for non-thermal cell clearance while preserving adjacent noncellular tissue [3] - Pulse Biosciences aims to develop its nPulse technology for treating atrial fibrillation and other markets, potentially enhancing healthcare outcomes for patients and providers, particularly in surgical soft tissue ablation [3]